Back to User profile » Dr Jisheng Chen
Papers published by Dr Jisheng Chen:
Health Technology Assessment of Oxazolidinones for MRSA-Associated Complicated Skin and Soft Tissue Infections
Zhao Y, Huang B, Yang Z, Kuang H, Chen J
Drug Design, Development and Therapy 2026, 20:551561
Published Date: 9 January 2026
Cost-Effectiveness of Once-Weekly Insulin Icodec versus Daily Basal Insulins in Chinese Adults with T2DM: A Treatment-Background Stratified Analysis
Xie Z, Deng W, Liang Z, Xie Y, Chen J, Cao W
ClinicoEconomics and Outcomes Research 2025, 17:771-787
Published Date: 27 October 2025
Characteristics and Efficacy of Warfarin Sodium Tablet Subdivided by 3D Printing Technology: A Retrospective Cohort Study of Patients After Prosthetic Valve Replacement
Lv J, Fu K, Xiong L, Chen B, Zhan L, Liu J, Lin Z, Yang F, Chen J
Drug Design, Development and Therapy 2025, 19:6089-6109
Published Date: 16 July 2025
Health Technology Assessment: Evaluation of 8 CGRP-Targeted Therapy Drugs for the Treatment of Migraine
Li M, Huang S, Li J, Hu X, Chen J
Drug Design, Development and Therapy 2025, 19:1231-1247
Published Date: 19 February 2025
Comprehensive Assessment of PCSK9 Inhibitors for Lipid Management: Scientific Guidance Based on Drug Selection Recommendations for Chinese Medical Institutions
Li J, Huang S, Hu X, Chen J
Drug Design, Development and Therapy 2024, 18:6297-6312
Published Date: 27 December 2024
A Health Technology Assessment Based on Chinese Guideline: Active Vitamin D and Its Analogs in the Treatment of Osteoporosis
Huang S, Li J, Hu X, Chen J
Drug Design, Development and Therapy 2024, 18:2593-2608
Published Date: 26 June 2024
Health Technology Assessment: Evaluation of 7 Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Type 2 Diabetes Mellitus
Xie Z, Hu J, Li M, Hu X, Chen J
Risk Management and Healthcare Policy 2024, 17:1053-1067
Published Date: 23 April 2024
Efficacy and Safety of Liraglutide and Semaglutide on Weight Loss in People with Obesity or Overweight: A Systematic Review
Xie Z, Yang S, Deng W, Li J, Chen J
Clinical Epidemiology 2022, 14:1463-1476
Published Date: 6 December 2022
A Health Technology Assessment Based on Chinese Guidelines: Glucagon-Like Peptide-1 Receptor Agonist in the Treatment of Type 2 Diabetes Complicated with Cardiovascular Disease
Xie Z, Li J, Yang S, Deng W, Chen J
Therapeutics and Clinical Risk Management 2022, 18:889-900
Published Date: 30 August 2022